Literature DB >> 9841495

Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I.

M J Horney1, D W Shirley, D T Kurtz, S A Rosenzweig.   

Abstract

To determine the effects of glucose on insulin-like growth factor I (IGF-I)-induced mesangial cell (MC) proliferation, we have examined the relationships between IGF binding protein 2 (IGFBP-2) secretion and proliferation in murine MCs (MMCs). MMCs incubated in high glucose (HG, 25 mM) exhibited a 25-30% reduction in IGFBP-2 secretion compared with cells in normal glucose (NG, 5.6 mM). This loss was not due to cell surface binding; it correlated with a 3.1-fold decrease in IGFBP-2 mRNA. IGFBP-2 secretion was stimulated by IGF-I in NG but was unaltered in HG. Insulin treatment yielded similar results at 10-fold higher doses, indicating that this response is IGF-I receptor dependent. MMCs in HG displayed increased IGF-I-stimulated insulin receptor substrate-1/2 phosphorylation and activator protein-1 transcriptional activity compared with NG controls. Accordingly, although IGF-I was not proliferative in NG, it increased [3H]thymidine incorporation and cell number in HG to an extent proportional to the decrease in IGFBP-2. Thus hyperglycemia, as seen in diabetes, may increase MC IGF-I sensitivity by reducing IGFBP-2 expression, in turn increasing its proliferative and secretory responses and contributing to the development of diabetic glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841495     DOI: 10.1152/ajprenal.1998.274.6.F1045

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  What's new in the IGF-binding proteins?

Authors:  Steven A Rosenzweig
Journal:  Growth Horm IGF Res       Date:  2004-10       Impact factor: 2.372

2.  Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy.

Authors:  Jessica R Mader; Zachary T Resch; Gary R McLean; Jakob H Mikkelsen; Claus Oxvig; Ronald J Marler; Cheryl A Conover
Journal:  J Endocrinol       Date:  2013-09-06       Impact factor: 4.286

Review 3.  Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.

Authors:  Tetyana L Vasylyeva; Robert J Ferry
Journal:  Diabetes Res Clin Pract       Date:  2006-10-02       Impact factor: 5.602

Review 4.  Defining the pathway to insulin-like growth factor system targeting in cancer.

Authors:  Steven A Rosenzweig; Hanudatta S Atreya
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

5.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.

Authors:  Lori K Davis; Buel D Rodgers; Kevin M Kelley
Journal:  Endocrine       Date:  2008-04-08       Impact factor: 3.633

6.  Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.

Authors:  Lalit P Singh; Yan Jiang; Davis W Cheng
Journal:  Int J Biol Sci       Date:  2006-10-27       Impact factor: 6.580

Review 7.  Insulin-like growth factor system in cancer: novel targeted therapies.

Authors:  Varsha P Brahmkhatri; Chinmayi Prasanna; Hanudatta S Atreya
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

8.  Lack of type VIII collagen in mice ameliorates diabetic nephropathy.

Authors:  Ulrike Hopfer; Helmut Hopfer; Catherine Meyer-Schwesinger; Ivonne Loeffler; Naomi Fukai; Bjorn R Olsen; Rolf A K Stahl; Gunter Wolf
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.